Ascend Wellness (OTC:AAWH) Raised to “Hold” at Zacks Research

Ascend Wellness (OTC:AAWH) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday,Zacks.com reports.

Ascend Wellness Trading Down 5.0%

AAWH opened at $0.53 on Wednesday. The company has a debt-to-equity ratio of 2.61, a quick ratio of 0.80 and a current ratio of 1.47. The stock’s 50 day moving average price is $0.63 and its 200-day moving average price is $0.68. Ascend Wellness has a one year low of $0.26 and a one year high of $1.20. The stock has a market cap of $109.17 million, a price-to-earnings ratio of -1.30 and a beta of 1.11.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.